Stryker’s Q Guidance System received FDA clearance for cranial applications

pharmafile | February 20, 2023 | News story | Sales and Marketing  

Stryker, a medical technology company, has announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the FDA. Its system for spinal applications is currently on the market.

 

The Q Guidance system is an image-based planning and intraoperative guidance system. It is indicated for any medical condition where computer-assisted planning and execution would be helpful, and where a reference to a rigid anatomical structure can be identified. The system supports the accurate alignment of the Precision Targeting System with a pre-operatively planned approach; it tracks navigated instruments and displays the position and orientation of the instruments in patient images.

 

Specifically, the Q Guidance System with Cranial Guidance Software can be used with a range of instruments and accessories for navigated cranial procedures.

Advertisement

 

Robbie Robinson, president of Stryker’s Spine division, “The FDA clearance of Stryker’s Q Guidance System with Cranial Guidance Software is a key milestone, which will help lead the transformation of cranial navigation and surgery. Our robust pipeline of iterative launches reinforces our commitment to making industry-leading investments focused on providing advanced navigation products and differentiated technologies that our surgeon customers have come to expect.”

 

James Spargo


Related Content

No items found
The Gateway to Local Adoption Series

Latest content